Elixinol Medicinal marijuana

Elixinol crush Q2 sales…but is there more?

Australian hemp company Elixinol Global shared Q2 financial results in a press release issued on July 30th, with sales of A$8.0 million growing 111% from the prior year and by 21% from the prior quarter.

Medical Marijuana Organigram

Organigram posts stellar Q3 2018 results

Organigram Holdings released third-quarter financial results for the period that ended on May 31st  2018. Growth in production, dried flower sales, oil sales and inventory positions Organigram for successful launch of the adult recreational use market later this year.

2,902FansLike
59FollowersFollow